Integra LifeSciences Holdings Corporation Announces Amendment to Exchange Offer For Its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008

Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has waived a condition and extended the expiration date of its offer to exchange up to $120 million principal amount of new notes with a "net share settlement" mechanism for its currently outstanding 2 1/2% Contingent Convertible Subordinated Notes due 2008.

Back to news